ESSEX PHARMA DEVELOPMENT

Essex Pharma Development GmbH specialties include pharmaceutical analytics (to include large scale stability programs), as well as bioanalytics. In 2008, the development institute – located in Waltrop near Dortmund – was acquired by Merck & Co as part of the acquisition of the former Schering-Plough Corporation. Outside of the USA and Canada, the new Merck & Co. Inc. takes the corporate name “MSD.” The corporation is one of the world’s largest providers of innovative medications, vaccines, biological therapeutic preparations, consumer health products and veterinarian health products.